Zymergen Inc (ZY) Stock
ZY is no longer traded. Zymergen was delisted from the Nasdaq in October 2022.
Prices on this page are historical; the last trade was October 18, 2022 at $2.43.
Zymergen stock price history
ZY final trading statistics
- Final close
- $2.43
- Final trading day
- Oct 18, 2022
- Market cap at delisting
- $253.58M
- Shares outstanding
- 104.36M
- Final 52-week range
- $1.10 – $12.42
- Avg. volume (final 3 mo.)
- 1,322,546
- All-time high (split-adj.)
- $48.50 · Apr 2021
- All-time low (split-adj.)
- $1.12 · May 2022
- Return since IPO
- -93.5%
- Beta
- —
- Book value / share
- $2.28
- Price / book
- 1.07
Zymergen annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $16.74M | -$361.8M | -$9.45 |
| FY2020 | $13.28M | -$262.2M | -$0.77 |
| FY2019 | $15.42M | -$236.8M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Zymergen Inc
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.
Zymergen stock FAQ
What happened to Zymergen stock?
Zymergen stock was delisted from the Nasdaq. Its final close was $2.43 on October 18, 2022.
Is ZY stock still trading?
No. ZY was delisted from the Nasdaq in October 2022 and no longer trades on a U.S. exchange.
What was the last price of ZY stock?
ZY closed at $2.43 on its final trading day, October 18, 2022, for a market value of about $253.58M.
What were Zymergen's revenue and earnings in its last full fiscal year?
Zymergen reported revenue of $16.74M and net income of -$361.8M in fiscal 2021, its last full year as a public company.
When did Zymergen go public?
Zymergen Inc stock began trading on April 22, 2021.